Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 199Rectal Neoplasms 106Colonic Neoplasms 78Stomach Neoplasms 64Pancreatic Neoplasms 56Neoplasm Metastasis 50Esophageal Neoplasms 34Neoplasms 25Lymphoma 24Leukemia 24Adenocarcinoma Of Esophagus 22Burkitt Lymphoma 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Carcinoma, Hepatocellular 16Cholangiocarcinoma 15Adenocarcinoma 15Biliary Tract Neoplasms 12Gallbladder Neoplasms 9Bile Duct Neoplasms 8Lymphoma, Mantle-Cell 7Colorectal Cancer Metastatic 7Osteosarcoma 6Esophageal Squamous Cell Carcinoma 6Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Liver Neoplasms 5Dendritic Cell Sarcoma, Interdigitating 5Breast Neoplasms 5Sarcoma 4Peritoneal Neoplasms 4

Interventions

Paclitaxel 3Amifostine 3Vincristine 2Procarbazine 2haloperidol decanoate 1axicabtagene ciloleucel 1Thalidomide 1Tadalafil 1Surveys and Questionnaires 1SLI381 1Rituximab 1Radiotherapy 1Prednisolone 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Modafinil 1Methylphenidate 1Methotrexate 1Melphalan 1Lorazepam 1Leucovorin 1Interleukin 1 Receptor Antagonist Protein 1In Situ Hybridization, Fluorescence 1Glutamine 1Gene Expression Profiling 1Folfox protocol 1Fluorouracil 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neurotoxicity Syndromes × Leucovorin × Clear all
NCT00884767 2009-07-08

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

National Cancer Institute (NCI)

Phase 2 Unknown
206 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡